These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29980799)

  • 1. Dsg2 via Src-mediated transactivation shapes EGFR signaling towards cell adhesion.
    Ungewiß H; Rötzer V; Meir M; Fey C; Diefenbacher M; Schlegel N; Waschke J
    Cell Mol Life Sci; 2018 Nov; 75(22):4251-4268. PubMed ID: 29980799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmoglein 2 regulates the intestinal epithelial barrier via p38 mitogen-activated protein kinase.
    Ungewiß H; Vielmuth F; Suzuki ST; Maiser A; Harz H; Leonhardt H; Kugelmann D; Schlegel N; Waschke J
    Sci Rep; 2017 Jul; 7(1):6329. PubMed ID: 28740231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Src/Cav1-dependent activation of the EGFR by Dsg2.
    Overmiller AM; McGuinn KP; Roberts BJ; Cooper F; Brennan-Crispi DM; Deguchi T; Peltonen S; Wahl JK; Mahoney MG
    Oncotarget; 2016 Jun; 7(25):37536-37555. PubMed ID: 26918609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
    Jin R; Wang X; Zang R; Liu C; Zheng S; Li H; Sun N; He J
    Cancer Lett; 2020 Jul; 483():46-58. PubMed ID: 32272148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Desmoglein 2 Contributes to the Pathogenesis of Crohn's Disease.
    Spindler V; Meir M; Vigh B; Flemming S; Hütz K; Germer CT; Waschke J; Schlegel N
    Inflamm Bowel Dis; 2015 Oct; 21(10):2349-59. PubMed ID: 26115074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes.
    Hartlieb E; Rötzer V; Radeva M; Spindler V; Waschke J
    J Biol Chem; 2014 Jun; 289(24):17043-53. PubMed ID: 24782306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2.
    Klessner JL; Desai BV; Amargo EV; Getsios S; Green KJ
    Mol Biol Cell; 2009 Jan; 20(1):328-37. PubMed ID: 18987342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity.
    Schlegel N; Meir M; Heupel WM; Holthöfer B; Leube RE; Waschke J
    Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G774-83. PubMed ID: 20224006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation.
    Lee SH; Kim JM; Lee DG; Lee J; Park JG; Han TS; Cho HS; Cho YL; Bae KH; Park YJ; Lee SJ; Lee MS; Huh YM; Jo DY; Yun HJ; Jeon HJ; Kim N; Joo M; Kim JS; Lee HJ; Min JK
    Cell Death Differ; 2021 Mar; 28(3):968-984. PubMed ID: 32989241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desmoglein 2, but not desmocollin 2, protects intestinal epithelia from injury.
    Gross A; Pack LAP; Schacht GM; Kant S; Ungewiss H; Meir M; Schlegel N; Preisinger C; Boor P; Guldiken N; Krusche CA; Sellge G; Trautwein C; Waschke J; Heuser A; Leube RE; Strnad P
    Mucosal Immunol; 2018 Nov; 11(6):1630-1639. PubMed ID: 30115995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoglein 2 can undergo Ca
    Fuchs M; Kugelmann D; Schlegel N; Vielmuth F; Waschke J
    Biophys J; 2022 Apr; 121(7):1322-1335. PubMed ID: 35183520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signaling.
    Kamekura R; Kolegraff KN; Nava P; Hilgarth RS; Feng M; Parkos CA; Nusrat A
    Oncogene; 2014 Sep; 33(36):4531-6. PubMed ID: 24166502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.
    Hartlieb E; Kempf B; Partilla M; Vigh B; Spindler V; Waschke J
    PLoS One; 2013; 8(1):e53739. PubMed ID: 23326495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
    Schlegel N; Boerner K; Waschke J
    Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR inhibition leads to enhanced desmosome assembly and cardiomyocyte cohesion via ROCK activation.
    Shoykhet M; Dervishi O; Menauer P; Hiermaier M; Moztarzadeh S; Osterloh C; Ludwig RJ; Williams T; Gerull B; Kääb S; Clauss S; Schüttler D; Waschke J; Yeruva S
    JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36795511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.
    Lorch JH; Klessner J; Park JK; Getsios S; Wu YL; Stack MS; Green KJ
    J Biol Chem; 2004 Aug; 279(35):37191-200. PubMed ID: 15205458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of desmoglein 2 promotes tumorigenic behavior in pancreatic cancer cells.
    Hütz K; Zeiler J; Sachs L; Ormanns S; Spindler V
    Mol Carcinog; 2017 Aug; 56(8):1884-1895. PubMed ID: 28277619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial maturity influences EPEC-induced desmosomal alterations.
    Roxas JL; Vedantam G; Viswanathan VK
    Gut Microbes; 2019; 10(2):241-245. PubMed ID: 30183504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic cardiomyopathy related DSG2 mutations affect desmosomal cadherin binding kinetics.
    Dieding M; Debus JD; Kerkhoff R; Gaertner-Rommel A; Walhorn V; Milting H; Anselmetti D
    Sci Rep; 2017 Oct; 7(1):13791. PubMed ID: 29062102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmogenic cardiomyopathy-related cadherin variants affect desmosomal binding kinetics.
    Göz M; Pohl G; Steinecker SM; Walhorn V; Milting H; Anselmetti D
    J Mol Cell Cardiol; 2024 Oct; 195():36-44. PubMed ID: 39079569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.